Canada· CA-DIN-00522996
CHLORDIAZEPOXIDE
A chlordiazepoxide product containing chlordiazepoxide hydrochloride, registered in Canada by AA PHARMA INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Chlordiazepoxide is registered in 11 of 19 countries.
Countries holding a registration under ATC N05BA02 (chlordiazepoxide), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Chlordiazepoxide · ATC N05BA02
11 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CHLORDIAZEPOXIDE HYDROCHLORIDE
- Manufacturer
- AA PHARMA INC
- Country
- Canada (CA)
- ATC code
- N05BA02
- ATC class
- Chlordiazepoxide
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
143 interactions on record for chlordiazepoxide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlordiazepoxide · interactions on record
143 records
- 4 severe
- 88 moderate
- 24 minor
- 27 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chlordiazepoxide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesChlordiazepoxide HydrochlorideUnit Dose Solutions, Inc.
- United KingdomChlordiazepoxide 10mg capsulesActavis UK Ltd
- SpainHUBERPLEX 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULATeofarma S.R.L.
- FinlandRisolidActavis Group ehf.
- PolandEleniumTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- IrelandLibrium 10mg Hard CapsuleViatris Healthcare Limited
- IcelandRisolidTeva B.V.*
- GermanyLibrium TabsViatris Healthcare Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Czechia · Elenium
- Germany · Librium Tabs
- Denmark · Klopoxid ”dak”, Risolid
- Spain · Huberplex
- United Kingdom (Northern Ireland) · Chlordiazepoxide Genethics Europe, Chlordiazepoxide Special Concept Development (Uk)
- Greece · Oasil
- Hungary · Elenium
- Ireland · Librium
- Iceland · Risolid
- Italy · Librium
- Lithuania · Elenium
- Latvia · Elenium
- Poland · Elenium
- Slovakia · Elenium
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4751124-0ee3-4b7c-853d-dc2da5628a40 GET /v1/drugs/c4751124-0ee3-4b7c-853d-dc2da5628a40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00522996",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N05BA02",
"schedule": [
"Targeted (CDSA IV)"
],
"drug_code": "4279",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"CHLORDIAZEPOXIDE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about chlordiazepoxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.